Literature DB >> 33870801

Critical assessment of AI in drug discovery.

W Patrick Walters1, Regina Barzilay2.   

Abstract

Introduction: Artificial Intelligence (AI) has become a component of our everyday lives, with applications ranging from recommendations on what to buy to the analysis of radiology images. Many of the techniques originally developed for other fields such as language translation and computer vision are now being applied in drug discovery. AI has enabled multiple aspects of drug discovery including the analysis of high content screening data, and the design and synthesis of new molecules.Areas covered: This perspective provides an overview of the application of AI in several areas relevant to drug discovery including property prediction, molecule generation, image analysis, and organic synthesis planning.Expert opinion: While a variety of machine learning methods are now being routinely used to predict biological activity and ADME properties, methods of representing molecules continue to evolve. Molecule generation methods are relatively new and unproven but hold the potential to access new, unexplored areas of chemical space. The application of AI in drug discovery will continue to benefit from dedicated research, as well as AI developments in other fields. With this pairing algorithmic advancements and high-quality data, the impact of AI in drug discovery will continue to grow in the coming years.

Entities:  

Keywords:  Artificial intelligence; QSAR; generative models; image analysis; drug discovery; machine learning

Mesh:

Year:  2021        PMID: 33870801     DOI: 10.1080/17460441.2021.1915982

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  4 in total

1.  Comparing classification models-a practical tutorial.

Authors:  W Patrick Walters
Journal:  J Comput Aided Mol Des       Date:  2021-09-22       Impact factor: 4.179

2.  Deep Learning Algorithms Achieved Satisfactory Predictions When Trained on a Novel Collection of Anticoronavirus Molecules.

Authors:  Emna Harigua-Souiai; Mohamed Mahmoud Heinhane; Yosser Zina Abdelkrim; Oussama Souiai; Ines Abdeljaoued-Tej; Ikram Guizani
Journal:  Front Genet       Date:  2021-11-29       Impact factor: 4.599

3.  Explaining and avoiding failure modes in goal-directed generation of small molecules.

Authors:  Maxime Langevin; Rodolphe Vuilleumier; Marc Bianciotto
Journal:  J Cheminform       Date:  2022-04-01       Impact factor: 5.514

Review 4.  Computational methods directed towards drug repurposing for COVID-19: advantages and limitations.

Authors:  Prem Prakash Sharma; Meenakshi Bansal; Aaftaab Sethi; Lindomar Pena; Vijay Kumar Goel; Maria Grishina; Shubhra Chaturvedi; Dhruv Kumar; Brijesh Rathi
Journal:  RSC Adv       Date:  2021-11-10       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.